Literature DB >> 18649360

The mitotic checkpoint gene, SIL is regulated by E2F1.

Ayelet Erez1, Marie Chaussepied, Asher Castiel, Tina Colaizzo-Anas, Peter D Aplan, Doron Ginsberg, Shai Izraeli.   

Abstract

The SIL gene expression is increased in multiple cancers and correlates with the expression of mitotic spindle checkpoint genes and with increased metastatic potential. SIL regulates mitotic entry, organization of the mitotic spindle and cell survival. The E2F transcription factors regulate cell cycle progression by controlling the expression of genes mediating the G1/S transition. More recently, E2F has been shown to regulate mitotic spindle checkpoint genes as well. As SIL expression correlates with mitotic checkpoint genes, we hypothesized that SIL is regulated by E2F. We mined raw data of published experiments and performed new experiments by modification of E2F expression in cell lines, reporter assays and chromatin immunoprecipitation. Ectopic expression or endogenous activation of E2F induced the expression of SIL, while knockdown of E2F by shRNA, downregulated SIL expression. E2F activated SIL promoter by reporter assay and bound to SIL promoter in vivo. Taken together these data demonstrate that SIL is regulated by E2F. As SIL is essential for mitotic entry, E2F may regulate G2/M transition through the induction of SIL. Furthermore, as silencing of SIL cause apoptosis in cancer cells, these finding may have therapeutic relevance in tumors with constitutive activation of E2F.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649360      PMCID: PMC2693309          DOI: 10.1002/ijc.23665

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.

Authors:  S Y Lin; A R Black; D Kostic; S Pajovic; C N Hoover; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Expression of the SIL gene is correlated with growth induction and cellular proliferation.

Authors:  S Izraeli; T Colaizzo-Anas; V L Bertness; K Mani; P D Aplan; I R Kirsch
Journal:  Cell Growth Differ       Date:  1997-11

4.  The SIL gene is required for mouse embryonic axial development and left-right specification.

Authors:  S Izraeli; L A Lowe; V L Bertness; D J Good; D W Dorward; I R Kirsch; M R Kuehn
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

5.  Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.

Authors:  P D Aplan; D P Lombardi; A M Ginsberg; J Cossman; V L Bertness; I R Kirsch
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

6.  Cloning and characterization of the SIL promoter.

Authors:  Tina Colaizzo-Anas; Peter D Aplan
Journal:  Biochim Biophys Acta       Date:  2003-01-27

7.  Cloning and characterization of a murine SIL gene.

Authors:  N Collazo-Garcia; P Scherer; P D Aplan
Journal:  Genomics       Date:  1995-12-10       Impact factor: 5.736

8.  siRNA-mediated gene silencing: a global genome view.

Authors:  Dimitri Semizarov; Paul Kroeger; Stephen Fesik
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

9.  Identification of target genes of the p16INK4A-pRB-E2F pathway.

Authors:  Richard Vernell; Kristian Helin; Heiko Müller
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

10.  Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.

Authors:  Eva Hernando; Zaher Nahlé; Gloria Juan; Elena Diaz-Rodriguez; Miguel Alaminos; Michael Hemann; Loren Michel; Vivek Mittal; William Gerald; Robert Benezra; Scott W Lowe; Carlos Cordon-Cardo
Journal:  Nature       Date:  2004-08-12       Impact factor: 49.962

View more
  13 in total

1.  VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

Authors:  Sandrine Passemard; Vincent El Ghouzzi; Hala Nasser; Catherine Verney; Guilan Vodjdani; Adrien Lacaud; Sophie Lebon; Marc Laburthe; Patrick Robberecht; Jeannette Nardelli; Shyamala Mani; Alain Verloes; Pierre Gressens; Vincent Lelièvre
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

2.  Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.

Authors:  Wei-Hsun Hsu; Xiaoliang Zhao; Jianquan Zhu; In-Kyu Kim; Guanhua Rao; Justine McCutcheon; Shuo-Tse Hsu; Beverly Teicher; Bhaskar Kallakury; Afshin Dowlati; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2019-02-14       Impact factor: 15.609

Review 3.  p53: guardian of ploidy.

Authors:  Yael Aylon; Moshe Oren
Journal:  Mol Oncol       Date:  2011-07-30       Impact factor: 6.603

4.  The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr.

Authors:  Asher Castiel; Michal Mark Danieli; Ahuvit David; Sharon Moshkovitz; Peter D Aplan; Ilan R Kirsch; Michael Brandeis; Alwin Krämer; Shai Izraeli
Journal:  J Cell Sci       Date:  2011-01-18       Impact factor: 5.285

5.  AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development.

Authors:  Biplab Dasgupta; Jeffrey Milbrandt
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

6.  A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation.

Authors:  Esther Baruch; Tali Nizri-Megnaji; Oron Berkowitz; Doron Ginsberg
Journal:  Oncotarget       Date:  2021-05-25

Review 7.  The PLK4-STIL-SAS-6 module at the core of centriole duplication.

Authors:  Christian Arquint; Erich A Nigg
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

8.  NEK7 is required for G1 progression and procentriole formation.

Authors:  Akshari Gupta; Yuki Tsuchiya; Midori Ohta; Gen Shiratsuchi; Daiju Kitagawa
Journal:  Mol Biol Cell       Date:  2017-05-24       Impact factor: 4.138

9.  Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.

Authors:  Noa Rabinowicz; Lingegowda S Mangala; Kevin R Brown; Cintia Checa-Rodriguez; Asher Castiel; Oren Moskovich; Giulia Zarfati; Luba Trakhtenbrot; Adva Levy-Barda; Dahai Jiang; Cristian Rodriguez-Aguayo; Sunila Pradeep; Yael van Praag; Gabriel Lopez-Berestein; Ahuvit David; Ilya Novikov; Pablo Huertas; Robert Rottapel; Anil K Sood; Shai Izraeli
Journal:  Oncotarget       Date:  2017-04-18

10.  A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel.

Authors:  Or Bida; Moriah Gidoni; Diana Ideses; Sol Efroni; Doron Ginsberg
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.